ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

TNGX Tango Therapeutics Inc

8.93
0.54 (6.44%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,301,091
Bid Price 8.42
Ask Price 9.00
News -
Day High 9.12

Low
2.88

52 Week Range

High
13.03

Day Low 8.08
Share Name Share Symbol Market Stock Type
Tango Therapeutics Inc TNGX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.54 6.44% 8.93 19:00:00
Open Price Low Price High Price Close Price Previous Close
8.34 8.08 9.12 8.93 8.39
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
14,850 1,301,091 US$ 8.69 US$ 11,302,355 - 2.88 - 13.03
Last Trade Type Quantity Price Currency
18:42:00 2 US$ 8.91 USD

Tango Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
912.81M 101.99M - 36.53M -101.74M -1.00 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Tango Therapeutics News

Date Time Source News Article
6/07/202416:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/07/202416:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/07/202416:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/06/202415:06Edgar (US Regulatory)Form 8-K - Current report
6/05/202406:00Business WireTango Therapeutics to Present at the Goldman Sachs 45th..
5/23/202408:18PR Newswire (US)Medivir´s licensee, Tango Therapeutics, has discontinued..
5/23/202406:18Edgar (US Regulatory)Form 8-K - Current report
5/23/202406:00Business WireTango Therapeutics Announces Discontinuation of TNG348..
5/08/202406:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/08/202406:14Edgar (US Regulatory)Form 8-K - Current report
5/08/202406:00Business WireTango Therapeutics Reports First Quarter 2024 Financial..
4/01/202415:48Business WireTango Therapeutics Announces Inducement Grants Under Nasdaq..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No TNGX Message Board. Create One! See More Posts on TNGX Message Board See More Message Board Posts

Historical TNGX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week7.089.126.707.60707,0861.8526.13%
1 Month7.839.126.467.23600,2881.1014.05%
3 Months7.979.126.467.47553,3880.9612.05%
6 Months10.1113.0056.469.34623,734-1.18-11.67%
1 Year3.6713.032.888.371,049,3765.26143.32%
3 Years9.6118.842.478.01523,047-0.68-7.08%
5 Years9.6118.842.478.01523,047-0.68-7.08%

Tango Therapeutics Description

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer.

Your Recent History

Delayed Upgrade Clock